OMCL
Omnicell Inc
33.70$
+1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.6% | 45.6% | 33.7% | 37.4% | 36.7% | 38.9% | 45.5% | 36.4% | 39.9% | 41.7% | 38.4% | 34.4% | |
| 22.5% | 14.2% | 5.8% | 3.3% | 6.2% | 10.3% | 26.6% | 16.3% | 14.9% | 21.0% | 17.4% | 10.0% | |
| 22.5% | 14.2% | 5.8% | 3.3% | 6.2% | 11.0% | 27.2% | 16.8% | 15.5% | 21.5% | 18.0% | 10.7% | |
| 14.8% | 18.7% | 16.1% | 20.3% | 18.1% | 17.6% | 10.4% | 11.2% | 13.5% | 11.3% | 12.1% | 11.0% | |
| 5.6% | 8.1% | 7.4% | 9.8% | 9.3% | 8.7% | 5.3% | 5.6% | 6.7% | 4.9% | 4.2% | 5.1% | |
| 6.5% | 5.6% | 4.5% | 4.3% | 4.8% | 4.4% | 3.2% | 5.6% | 4.3% | – | – | – | |
| 21.9% | 25.6% | 35.0% | 34.5% | 31.1% | 27.1% | 27.4% | 34.5% | 33.2% | 33.0% | 34.6% | 37.4% | |
| 14.8% | 15.5% | 20.3% | 17.1% | 13.3% | 16.9% | 14.4% | 17.5% | 14.6% | 12.5% | 11.6% | 11.4% | |
| 30.4% | 30.5% | 53.8% | 47.2% | 37.1% | 31.9% | 47.0% | 46.5% | 48.9% | 46.6% | 41.4% | 37.6% | |
| 20.1% | 21.5% | 19.3% | 21.7% | 18.9% | 19.1% | 15.2% | 40.9% | 19.4% | 16.5% | 28.1% | 24.1% | |
| 0.9% | 1.4% | 0.9% | 1.6% | 0.8% | 0.8% | 0.7% | 23.4% | 0.5% | 0.5% | 8.7% | 0.6% | |
| 3.5% | 3.9% | 2.9% | 4.9% | 3.5% | 3.7% | 2.2% | 3.3% | 2.9% | 2.0% | 2.4% | 2.2% | |
| 0.0% | 0.0% | 26.3% | 19.9% | 12.5% | 4.0% | 25.6% | – | 25.6% | 25.6% | 7.8% | 8.5% | |
| 69.6% | 69.5% | 46.2% | 52.8% | 62.9% | 68.1% | 53.0% | 53.5% | 51.1% | 53.4% | 58.6% | 62.4% | |
| 12.3% | 17.2% | 10.7% | 12.5% | 18.3% | 20.9% | 15.9% | 17.2% | 17.7% | 16.6% | 18.1% | 19.5% | |
| 6.5% | 6.3% | 3.9% | 3.9% | 3.8% | 3.5% | 2.4% | 2.2% | 2.1% | 2.0% | 2.2% | 2.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.